Holen Sie sich die Stockscreener-App
3.015
1.52%
0.045
Handel nachbörslich:
3.06
0.045
+1.49%
Schlusskurs vom Vortag:
$2.97
Offen:
$2.95
24-Stunden-Volumen:
13,894
Relative Volume:
0.27
Marktkapitalisierung:
$16.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.35M
KGV:
-0.9885
EPS:
-3.05
Netto-Cashflow:
$-11.88M
1W Leistung:
-0.17%
1M Leistung:
-7.66%
6M Leistung:
-14.83%
1J Leistung:
-20.66%
1-Tages-Spanne:
$2.95
$3.0592
1-Wochen-Bereich:
$2.86
$3.10
52-Wochen-Spanne:
$2.6838
$6.1683
Lipocine Inc Stock (LPCN) Company Profile
Firmenname
Lipocine Inc
Sektor
Branche
Telefon
801 994 7383
Adresse
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Vergleichen Sie LPCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LPCN
Lipocine Inc
|
3.015 | 16.09M | 0 | -16.35M | -11.88M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-06-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-01-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-12-08 | Fortgesetzt | H.C. Wainwright | Buy |
| 2016-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-07-22 | Eingeleitet | ROTH Capital | Buy |
| 2015-06-23 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Lipocine Inc Aktie (LPCN) Neueste Nachrichten
Multi factor analysis applied to Lipocine Inc.July 2025 EndofMonth & Real-Time Volume Triggers - Newser
What machine learning models say about Lipocine Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Lipocine Inc. stock trend outlook and recovery pathJuly 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Pattern recognition hints at Lipocine Inc. upsideTrade Ideas Based on Fundamental Metrics - Newser
Real time alert setup for Lipocine Inc. performanceJuly 2025 Trends & Precise Trade Entry Recommendations - Newser
Tools to assess Lipocine Inc.’s risk profileCommunity Picked Stocks with Trade Insights - Newser
Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO) as a Treatment for Postpartum Depression on July 9, 2025 - 富途牛牛
Combining price and volume data for Lipocine Inc.Low Risk Stock Selection Strategy Guide - Newser
When is the best time to exit Lipocine Inc.Historical Volatility and Pattern Breakdown Analysis - Newser
Postpartum Depression Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences Limited - Barchart.com
What earnings revisions data tells us about Lipocine Inc.AI Trend Detection for Entry Timing - Newser
Detecting support and resistance levels for Lipocine Inc.Daily Market Entry Strategy with Tools - Newser
What makes Lipocine Inc. stock price move sharplySwing Candidate List with Trade Cues - Newser
Is Lipocine Inc. reversing from oversold territoryReal-Time Signal Tracking with Entry Level - Newser
Lipocine Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingBull Market Summary and Recovery Outlook - Newser
Moving Average Trends for Lipocine Inc. Stock: What They IndicateFree Pattern Breakout Entry Stock Forecast - Newser
Lipocine (LPCN) Projected to Post Earnings on Thursday - Defense World
Lipocine: Q2 Earnings Snapshot - New Haven Register
Lipocine Inc. Reports Q2 2025 Financial Results - TipRanks
Lipocine Inc.’s volatility index tracking explainedWeekly Price Target Forecast and Alerts - Newser
Lipocine Reports 29% Smaller Loss as PPD Drug Trial Progresses, Targets $70B GLP-1 Market - Stock Titan
Lipocine Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
What is Lipocine Inc. company’s growth strategyRapid-fire capital growth - Jammu Links News
What analysts say about Lipocine Inc. stockMaximize portfolio growth with strategic plans - Jammu Links News
What drives Lipocine Inc. stock priceAchieve rapid portfolio growth with smart picks - Jammu Links News
Should I hold or sell Lipocine Inc. stock in 2025Free Predictions - Jammu Links News
What are the latest earnings results for Lipocine Inc.High-yield growth strategies - Jammu Links News
How strong is Lipocine Inc. company’s balance sheetUnlock powerful trading signals for profits - Jammu Links News
Is it the right time to buy Lipocine Inc. stockExponential wealth increase - Jammu Links News
Is Lipocine Inc. a growth stock or a value stockFree Stock Market Query - Jammu Links News
Candlestick signals on Lipocine Inc. stock todayFree Stock Market Entry Timing Signals - Newser
What are Lipocine Inc. company’s key revenue driversFree Investment Community - Jammu Links News
How does Lipocine Inc. compare to its industry peersFree Market Volatility Navigation Tips - Jammu Links News
Why is Lipocine Inc. stock attracting strong analyst attentionExceptional portfolio growth - Jammu Links News
How volatile is Lipocine Inc. stock compared to the marketMaximize portfolio value with expert tips - Jammu Links News
Using fundamentals and technicals on Lipocine Inc.Swing Watchlist With Tight Stop Placement - Newser
Finanzdaten der Lipocine Inc-Aktie (LPCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):